Neurological Disorder Drugs and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Neurological Disorder Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Neurological Disorder Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Neurological Disorder Drugs Overall Market Size
2.1 Global Neurological Disorder Drugs Market Size: 2023 VS 2030
2.2 Global Neurological Disorder Drugs Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Neurological Disorder Drugs Players in Global Market
3.2 Top Global Neurological Disorder Drugs Companies Ranked by Revenue
3.3 Global Neurological Disorder Drugs Revenue by Companies
3.4 Top 3 and Top 5 Neurological Disorder Drugs Companies in Global Market, by Revenue in 2023
3.5 Global Companies Neurological Disorder Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Neurological Disorder Drugs Players in Global Market
3.6.1 List of Global Tier 1 Neurological Disorder Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Neurological Disorder Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Neurological Disorder Drugs Market Size Markets, 2023 & 2030
4.1.2 Antipsychotic
4.1.3 Hypnotic & Sedative
4.1.4 Analgesics
4.1.5 Anticoagulants
4.1.6 Others
4.2 By Type - Global Neurological Disorder Drugs Revenue & Forecasts
4.2.1 By Type - Global Neurological Disorder Drugs Revenue, 2019-2024
4.2.2 By Type - Global Neurological Disorder Drugs Revenue, 2025-2030
4.2.3 By Type - Global Neurological Disorder Drugs Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Neurological Disorder Drugs Market Size, 2023 & 2030
5.1.2 Hospital
5.1.3 Clinic
5.2 By Application - Global Neurological Disorder Drugs Revenue & Forecasts
5.2.1 By Application - Global Neurological Disorder Drugs Revenue, 2019-2024
5.2.2 By Application - Global Neurological Disorder Drugs Revenue, 2025-2030
5.2.3 By Application - Global Neurological Disorder Drugs Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Neurological Disorder Drugs Market Size, 2023 & 2030
6.2 By Region - Global Neurological Disorder Drugs Revenue & Forecasts
6.2.1 By Region - Global Neurological Disorder Drugs Revenue, 2019-2024
6.2.2 By Region - Global Neurological Disorder Drugs Revenue, 2025-2030
6.2.3 By Region - Global Neurological Disorder Drugs Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Neurological Disorder Drugs Revenue, 2019-2030
6.3.2 US Neurological Disorder Drugs Market Size, 2019-2030
6.3.3 Canada Neurological Disorder Drugs Market Size, 2019-2030
6.3.4 Mexico Neurological Disorder Drugs Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Neurological Disorder Drugs Revenue, 2019-2030
6.4.2 Germany Neurological Disorder Drugs Market Size, 2019-2030
6.4.3 France Neurological Disorder Drugs Market Size, 2019-2030
6.4.4 U.K. Neurological Disorder Drugs Market Size, 2019-2030
6.4.5 Italy Neurological Disorder Drugs Market Size, 2019-2030
6.4.6 Russia Neurological Disorder Drugs Market Size, 2019-2030
6.4.7 Nordic Countries Neurological Disorder Drugs Market Size, 2019-2030
6.4.8 Benelux Neurological Disorder Drugs Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Neurological Disorder Drugs Revenue, 2019-2030
6.5.2 China Neurological Disorder Drugs Market Size, 2019-2030
6.5.3 Japan Neurological Disorder Drugs Market Size, 2019-2030
6.5.4 South Korea Neurological Disorder Drugs Market Size, 2019-2030
6.5.5 Southeast Asia Neurological Disorder Drugs Market Size, 2019-2030
6.5.6 India Neurological Disorder Drugs Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Neurological Disorder Drugs Revenue, 2019-2030
6.6.2 Brazil Neurological Disorder Drugs Market Size, 2019-2030
6.6.3 Argentina Neurological Disorder Drugs Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Neurological Disorder Drugs Revenue, 2019-2030
6.7.2 Turkey Neurological Disorder Drugs Market Size, 2019-2030
6.7.3 Israel Neurological Disorder Drugs Market Size, 2019-2030
6.7.4 Saudi Arabia Neurological Disorder Drugs Market Size, 2019-2030
6.7.5 UAE Neurological Disorder Drugs Market Size, 2019-2030
7 Neurological Disorder Drugs Companies Profiles
7.1 Novartis
7.1.1 Novartis Company Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Neurological Disorder Drugs Major Product Offerings
7.1.4 Novartis Neurological Disorder Drugs Revenue in Global Market (2019-2024)
7.1.5 Novartis Key News & Latest Developments
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Company Summary
7.2.2 GlaxoSmithKline Business Overview
7.2.3 GlaxoSmithKline Neurological Disorder Drugs Major Product Offerings
7.2.4 GlaxoSmithKline Neurological Disorder Drugs Revenue in Global Market (2019-2024)
7.2.5 GlaxoSmithKline Key News & Latest Developments
7.3 Merck & Co.
7.3.1 Merck & Co. Company Summary
7.3.2 Merck & Co. Business Overview
7.3.3 Merck & Co. Neurological Disorder Drugs Major Product Offerings
7.3.4 Merck & Co. Neurological Disorder Drugs Revenue in Global Market (2019-2024)
7.3.5 Merck & Co. Key News & Latest Developments
7.4 Bayer
7.4.1 Bayer Company Summary
7.4.2 Bayer Business Overview
7.4.3 Bayer Neurological Disorder Drugs Major Product Offerings
7.4.4 Bayer Neurological Disorder Drugs Revenue in Global Market (2019-2024)
7.4.5 Bayer Key News & Latest Developments
7.5 AstraZeneca
7.5.1 AstraZeneca Company Summary
7.5.2 AstraZeneca Business Overview
7.5.3 AstraZeneca Neurological Disorder Drugs Major Product Offerings
7.5.4 AstraZeneca Neurological Disorder Drugs Revenue in Global Market (2019-2024)
7.5.5 AstraZeneca Key News & Latest Developments
7.6 Boehringer Ingelheim
7.6.1 Boehringer Ingelheim Company Summary
7.6.2 Boehringer Ingelheim Business Overview
7.6.3 Boehringer Ingelheim Neurological Disorder Drugs Major Product Offerings
7.6.4 Boehringer Ingelheim Neurological Disorder Drugs Revenue in Global Market (2019-2024)
7.6.5 Boehringer Ingelheim Key News & Latest Developments
7.7 Teva Pharmaceutical
7.7.1 Teva Pharmaceutical Company Summary
7.7.2 Teva Pharmaceutical Business Overview
7.7.3 Teva Pharmaceutical Neurological Disorder Drugs Major Product Offerings
7.7.4 Teva Pharmaceutical Neurological Disorder Drugs Revenue in Global Market (2019-2024)
7.7.5 Teva Pharmaceutical Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Neurological Disorder Drugs Market Opportunities & Trends in Global Market
Table 2. Neurological Disorder Drugs Market Drivers in Global Market
Table 3. Neurological Disorder Drugs Market Restraints in Global Market
Table 4. Key Players of Neurological Disorder Drugs in Global Market
Table 5. Top Neurological Disorder Drugs Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Neurological Disorder Drugs Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Neurological Disorder Drugs Revenue Share by Companies, 2019-2024
Table 8. Global Companies Neurological Disorder Drugs Product Type
Table 9. List of Global Tier 1 Neurological Disorder Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Neurological Disorder Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Neurological Disorder Drugs Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Neurological Disorder Drugs Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Neurological Disorder Drugs Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Neurological Disorder Drugs Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Neurological Disorder Drugs Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Neurological Disorder Drugs Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Neurological Disorder Drugs Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Neurological Disorder Drugs Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Neurological Disorder Drugs Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Neurological Disorder Drugs Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Neurological Disorder Drugs Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Neurological Disorder Drugs Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Neurological Disorder Drugs Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Neurological Disorder Drugs Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Neurological Disorder Drugs Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Neurological Disorder Drugs Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Neurological Disorder Drugs Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Neurological Disorder Drugs Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Neurological Disorder Drugs Revenue, (US$, Mn), 2025-2030
Table 30. Novartis Company Summary
Table 31. Novartis Neurological Disorder Drugs Product Offerings
Table 32. Novartis Neurological Disorder Drugs Revenue (US$, Mn) & (2019-2024)
Table 33. Novartis Key News & Latest Developments
Table 34. GlaxoSmithKline Company Summary
Table 35. GlaxoSmithKline Neurological Disorder Drugs Product Offerings
Table 36. GlaxoSmithKline Neurological Disorder Drugs Revenue (US$, Mn) & (2019-2024)
Table 37. GlaxoSmithKline Key News & Latest Developments
Table 38. Merck & Co. Company Summary
Table 39. Merck & Co. Neurological Disorder Drugs Product Offerings
Table 40. Merck & Co. Neurological Disorder Drugs Revenue (US$, Mn) & (2019-2024)
Table 41. Merck & Co. Key News & Latest Developments
Table 42. Bayer Company Summary
Table 43. Bayer Neurological Disorder Drugs Product Offerings
Table 44. Bayer Neurological Disorder Drugs Revenue (US$, Mn) & (2019-2024)
Table 45. Bayer Key News & Latest Developments
Table 46. AstraZeneca Company Summary
Table 47. AstraZeneca Neurological Disorder Drugs Product Offerings
Table 48. AstraZeneca Neurological Disorder Drugs Revenue (US$, Mn) & (2019-2024)
Table 49. AstraZeneca Key News & Latest Developments
Table 50. Boehringer Ingelheim Company Summary
Table 51. Boehringer Ingelheim Neurological Disorder Drugs Product Offerings
Table 52. Boehringer Ingelheim Neurological Disorder Drugs Revenue (US$, Mn) & (2019-2024)
Table 53. Boehringer Ingelheim Key News & Latest Developments
Table 54. Teva Pharmaceutical Company Summary
Table 55. Teva Pharmaceutical Neurological Disorder Drugs Product Offerings
Table 56. Teva Pharmaceutical Neurological Disorder Drugs Revenue (US$, Mn) & (2019-2024)
Table 57. Teva Pharmaceutical Key News & Latest Developments
List of Figures
Figure 1. Neurological Disorder Drugs Segment by Type in 2023
Figure 2. Neurological Disorder Drugs Segment by Application in 2023
Figure 3. Global Neurological Disorder Drugs Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Neurological Disorder Drugs Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Neurological Disorder Drugs Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Neurological Disorder Drugs Revenue in 2023
Figure 8. By Type - Global Neurological Disorder Drugs Revenue Market Share, 2019-2030
Figure 9. By Application - Global Neurological Disorder Drugs Revenue Market Share, 2019-2030
Figure 10. By Type - Global Neurological Disorder Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Neurological Disorder Drugs Revenue Market Share, 2019-2030
Figure 12. By Application - Global Neurological Disorder Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Neurological Disorder Drugs Revenue Market Share, 2019-2030
Figure 14. By Region - Global Neurological Disorder Drugs Revenue Market Share, 2019-2030
Figure 15. By Country - North America Neurological Disorder Drugs Revenue Market Share, 2019-2030
Figure 16. US Neurological Disorder Drugs Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Neurological Disorder Drugs Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Neurological Disorder Drugs Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Neurological Disorder Drugs Revenue Market Share, 2019-2030
Figure 20. Germany Neurological Disorder Drugs Revenue, (US$, Mn), 2019-2030
Figure 21. France Neurological Disorder Drugs Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Neurological Disorder Drugs Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Neurological Disorder Drugs Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Neurological Disorder Drugs Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Neurological Disorder Drugs Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Neurological Disorder Drugs Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Neurological Disorder Drugs Revenue Market Share, 2019-2030
Figure 28. China Neurological Disorder Drugs Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Neurological Disorder Drugs Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Neurological Disorder Drugs Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Neurological Disorder Drugs Revenue, (US$, Mn), 2019-2030
Figure 32. India Neurological Disorder Drugs Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Neurological Disorder Drugs Revenue Market Share, 2019-2030
Figure 34. Brazil Neurological Disorder Drugs Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Neurological Disorder Drugs Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Neurological Disorder Drugs Revenue Market Share, 2019-2030
Figure 37. Turkey Neurological Disorder Drugs Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Neurological Disorder Drugs Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Neurological Disorder Drugs Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Neurological Disorder Drugs Revenue, (US$, Mn), 2019-2030
Figure 41. Novartis Neurological Disorder Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. GlaxoSmithKline Neurological Disorder Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Merck & Co. Neurological Disorder Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Bayer Neurological Disorder Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. AstraZeneca Neurological Disorder Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Boehringer Ingelheim Neurological Disorder Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Teva Pharmaceutical Neurological Disorder Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
